Patents by Inventor Scott Ludecker
Scott Ludecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11839390Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: April 13, 2021Date of Patent: December 12, 2023Assignee: MISONIX, LLCInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Patent number: 11147570Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: February 6, 2019Date of Patent: October 19, 2021Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20210228225Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: April 13, 2021Publication date: July 29, 2021Inventors: PAUL MIKUS, SCOTT ISOLA, DAN VOIC, SCOTT LUDECKER, ALEXANDER DARIAN
-
Patent number: 10973537Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: September 10, 2018Date of Patent: April 13, 2021Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20190167285Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: February 6, 2019Publication date: June 6, 2019Inventors: Paul MIKUS, Scott ISOLA, Dan VOIC, Scott LUDECKER, Alexander DARIAN
-
Patent number: 10299809Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: November 5, 2015Date of Patent: May 28, 2019Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20190015123Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: September 10, 2018Publication date: January 17, 2019Inventors: PAUL MIKUS, Scott ISOLA, Dan VOIC, Scott LUDECKER, Alexander DARIAN
-
Patent number: 10092308Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: November 12, 2015Date of Patent: October 9, 2018Assignee: MISONIX, INC.Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20160128708Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: November 12, 2015Publication date: May 12, 2016Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20160128707Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: November 5, 2015Publication date: May 12, 2016Inventors: PAUL MIKUS, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Patent number: 6932308Abstract: An apparatus for adjustably securing an ultrasonic transducer to an orthopedic appliance is disclosed. The apparatus having; (a) an optional adjustable clamp adapted to adjustably secure the apparatus to an element of an orthopedic appliance; (b) a transducer holder adapted to secure the transducer to the apparatus; (c) an adjustable connector adapted to adjustably connect the optional adjustable clamp to the transducer holder.Type: GrantFiled: October 25, 2001Date of Patent: August 23, 2005Assignee: Exogen, Inc.Inventors: Roger J. Talish, Kenneth J. Urgovitch, Donald E. Krompasick, Anthony James, Wayne Rankhorn, Kevin Tanis, Robert Scott Ludecker
-
Publication number: 20020145091Abstract: The invention relates to an apparatus for adjustably securing an ultrasonic transducer to an orthopedic appliance, having:Type: ApplicationFiled: October 25, 2001Publication date: October 10, 2002Inventors: Roger J. Talish, Kenneth J. Urgovich, Donald E. Krompasick, Anthony James, Wayne Rankhorn, Kevin Tanis, Robert Scott Ludecker
-
Patent number: 6165144Abstract: An apparatus and method for mounting an ultrasound transducer head module. The apparatus includes an insert having an axial bore therein and a plurality of tabs extending radially therefrom. A spacer is provided and configured to fit within a void in a cast. The spacer has a hole therein to insertably receive the insert. An ultrasound transmission-enhancing medium is positioned within the hole in the spacer and adjacent a treatment location. The ultrasound treatment head module is then positioned within the insert and means for biasing it toward the ultrasound transmission-enhancing medium is provided. A strap may be provided to secure the apparatus adjacent a body portion to be treated, with or without the existence of a cast.Type: GrantFiled: March 17, 1998Date of Patent: December 26, 2000Assignee: Exogen, Inc.Inventors: Roger Talish, Kenneth Urgovitch, Sr., Donald E. Krompasick, Robert Scott Ludecker, Emery Rose